UnitedHealth Group, the largest health insurance company in the United States, recently made its first public appearance since the tragic killing of a top executive, CEO Brian Thompson. The aftermath of Thompson’s death led to a wave of discontent and frustration towards health insurance companies, resulting in a significant drop in UnitedHealth’s stock value.
During the earnings call, UnitedHealth CEO Andrew Witty acknowledged the public’s dissatisfaction with the health care system, attributing the high costs to the exorbitant prices set by drug companies and hospitals. Witty emphasized the need for a simpler, more affordable health care system while defending his company’s role in the industry. UnitedHealth reported over $400 billion in revenue and $14.4 billion in net profit for the previous year.
Thompson, the deceased executive, was remembered by Witty for his dedication to improving the health care system for all individuals served by UnitedHealth. The company has not yet announced a replacement for Thompson.
UnitedHealth is currently under intense scrutiny from both members and regulators for its dominant position in the health care market. Witty took aim at hospitals, suggesting that certain participants in the system benefit from inflated prices, which contribute to the overall high costs of health care in the U.S. He also criticized the pharmaceutical industry for their pricing practices, citing examples where drug prices in the U.S. are significantly higher than in other countries.
Despite the efforts of insurers and pharmacy benefit managers, including UnitedHealth’s Optum Rx, to negotiate lower prices with drug companies, the high cost of prescription medications remains a major issue. Witty defended PBMs, stating that Optum Rx plans to pass 100% of drug rebates back to consumers and employers by 2028 to increase transparency in drug pricing.
On the financial front, UnitedHealth faced challenges in the fourth quarter, with revenue falling short of expectations. The company’s stock value declined as a result of ongoing struggles in Medicare Advantage, where changes implemented by the Biden administration have impacted profitability.
UnitedHealth’s earnings call shed light on the complexities and challenges facing the U.S. health care system, emphasizing the need for transparency, affordability, and accountability among all participants in the industry. After states culled their Medicaid programs of people who were no longer eligible in 2023, it was found that those remaining on Medicaid tended to need more care. This increase in care required by Medicaid recipients resulted in UnitedHealth reporting a higher medical loss ratio in 2024 compared to the previous year.
UnitedHealth, a major health insurance company, reported a medical loss ratio of 85.5% in 2024, which was higher than both analysts’ and the company’s own projections. This ratio indicates the percentage of premiums spent on medical care, with federal law mandating that insurers spend a minimum of 80% to 85% of premiums on medical services.
During a call with investors, John Rex, UnitedHealth’s chief financial officer, attributed 70% of the increased medical costs to issues with Medicare Advantage and Medicaid. He explained that Medicare Advantage enrollees required more care, and the company did not see the expected growth in membership due to changes in benefit design. Additionally, in the Medicaid program, state payment rates were not keeping pace with the health needs of members.
The remaining 30% of the increased medical costs was attributed to covering high-cost drugs and an aggressive upshift in hospital coding practices. Despite these challenges, UnitedHealth announced plans to expand its Medicare Advantage program by up to 800,000 members in the coming year.
However, experts have raised concerns about the cost-effectiveness of Medicare Advantage plans, as the government pays these plans more than traditional Medicare on average. In 2024, Medicare Advantage plans received 108% of traditional Medicare payments, which increased to 132% when accounting for insurers’ coding practices and their ability to attract healthier individuals.
UnitedHealth’s net profit in 2024 was $14.4 billion, a 36% decrease from the previous year. This decline was attributed to the higher medical costs incurred, as well as expenses related to the Change Healthcare cyberattack.
In conclusion, the increase in care required by Medicaid recipients after the culling of ineligible individuals in 2023 has led to higher medical costs for insurers like UnitedHealth. As the company navigates these challenges, it continues to focus on expanding its Medicare Advantage program while facing scrutiny over the cost-effectiveness of such plans.
